Essex Bio-Technology Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Haizhou Fang
Chief executive officer
HK$1.7m
Total compensation
| CEO salary percentage | 97.5% |
| CEO tenure | no data |
| CEO ownership | 0.9% |
| Management average tenure | 23.3yrs |
| Board average tenure | 3.7yrs |
Recent management updates
Recent updates
Essex Bio-Technology Limited's (HKG:1061) Low P/E No Reason For Excitement
May 06
Calculating The Fair Value Of Essex Bio-Technology Limited (HKG:1061)
Mar 21Essex Bio-Technology (HKG:1061) Has A Pretty Healthy Balance Sheet
Dec 07Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly
Dec 07Essex Bio-Technology (HKG:1061) Is Due To Pay A Dividend Of HK$0.04
Aug 25Is Essex Bio-Technology (HKG:1061) Using Too Much Debt?
Jun 22Essex Bio-Technology (HKG:1061) Has Announced That It Will Be Increasing Its Dividend To HK$0.055
May 02Essex Bio-Technology (HKG:1061) Will Pay A Larger Dividend Than Last Year At HK$0.055
Mar 30Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly
Jun 29Is Essex Bio-Technology (HKG:1061) A Risky Investment?
Mar 31If You Had Bought Essex Bio-Technology (HKG:1061) Stock Five Years Ago, You Could Pocket A 40% Gain Today
Mar 13How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?
Feb 15
Do Institutions Own Essex Bio-Technology Limited (HKG:1061) Shares?
Jan 25Essex Bio-Technology Limited's (HKG:1061) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
Jan 04Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly
Dec 13Why Essex Bio-Technology's (HKG:1061) CEO Pay Matters
Nov 23CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | HK$2m | HK$2m | HK$275m |
| Sep 30 2023 | n/a | n/a | HK$266m |
| Jun 30 2023 | n/a | n/a | HK$256m |
| Mar 31 2023 | n/a | n/a | HK$241m |
| Dec 31 2022 | HK$2m | HK$2m | HK$225m |
| Sep 30 2022 | n/a | n/a | HK$274m |
| Jun 30 2022 | n/a | n/a | HK$323m |
| Mar 31 2022 | n/a | n/a | HK$334m |
| Dec 31 2021 | HK$2m | HK$2m | HK$346m |
| Sep 30 2021 | n/a | n/a | HK$339m |
| Jun 30 2021 | n/a | n/a | HK$332m |
| Mar 31 2021 | n/a | n/a | HK$275m |
| Dec 31 2020 | HK$2m | HK$2m | HK$219m |
| Sep 30 2020 | n/a | n/a | HK$221m |
| Jun 30 2020 | n/a | n/a | HK$222m |
| Mar 31 2020 | n/a | n/a | HK$262m |
| Dec 31 2019 | HK$2m | HK$737k | HK$303m |
| Sep 30 2019 | n/a | n/a | HK$282m |
| Jun 30 2019 | n/a | n/a | HK$262m |
| Mar 31 2019 | n/a | n/a | HK$246m |
| Dec 31 2018 | HK$2m | HK$766k | HK$231m |
| Sep 30 2018 | n/a | n/a | HK$210m |
| Jun 30 2018 | n/a | n/a | HK$189m |
| Mar 31 2018 | n/a | n/a | HK$178m |
| Dec 31 2017 | HK$2m | HK$721k | HK$167m |
Compensation vs Market: Haizhou's total compensation ($USD223.65K) is below average for companies of similar size in the Hong Kong market ($USD342.67K).
Compensation vs Earnings: Haizhou's compensation has been consistent with company performance over the past year.
CEO
Haizhou Fang (57 yo)
no data
Tenure
HK$1,744,587
Compensation
Mr. Haizhou Fang serves as the Managing Director and Executive Director of Essex Bio-Technology Limited and served as its General Manager. Mr. Fang is qualified as a Senior Pharmaceutical Engineer (Profess...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Chairman | no data | HK$3.23m | 52.74% HK$ 778.2m | |
| MD & Executive Director | no data | HK$1.74m | 0.92% HK$ 13.6m | |
| Executive Director & Deputy MD | no data | HK$1.80m | 0.36% HK$ 5.3m | |
| Executive Director & Company Secretary | 23.3yrs | HK$755.60k | 0.0081% HK$ 119.7k | |
| Group Chief Scientific Officer | 6.1yrs | no data | no data |
23.3yrs
Average Tenure
59yo
Average Age
Experienced Management: 1061's management team is seasoned and experienced (23.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Chairman | no data | HK$3.23m | 52.74% HK$ 778.2m | |
| MD & Executive Director | no data | HK$1.74m | 0.92% HK$ 13.6m | |
| Executive Director & Deputy MD | 3.7yrs | HK$1.80m | 0.36% HK$ 5.3m | |
| Executive Director & Company Secretary | 3.7yrs | HK$755.60k | 0.0081% HK$ 119.7k | |
| Independent Non Executive Director | 22.9yrs | HK$250.00k | no data | |
| Independent Non Executive Director | 19.7yrs | HK$220.00k | no data | |
| Independent Non-Executive Director | less than a year | HK$128.33k | no data |
3.7yrs
Average Tenure
60yo
Average Age
Experienced Board: 1061's board of directors are considered experienced (3.7 years average tenure).